PediaMed Ventures · Last-Mile Investment
Advancing pediatric therapies that are both clinically meaningful and commercially viable — validated medicines that stall before reaching children, and the expertise to finish them.
Investment Thesis
We invest where the science is largely settled but execution has stalled — pediatric medicines that are both clinically meaningful and commercially viable, refusing to treat the two as a trade-off.
Outcome — drives approval, adoption, and sustainable scale.
Focus Areas
Late-stage and approved therapies where the science is resolved but momentum has stalled.
Established therapies never advanced into the pediatric indications children need.
Pediatric-labeled medicines that exist but never reach the children who need them.
Assets parked after portfolio shifts — with a clear path forward.
Platform Advantage
PediaMed combines investment discipline with deep commercialization expertise — helping portfolio companies accelerate growth and patient access alike.
Most investors stop at the check. We bring the operating capability to turn a promising pediatric asset into a therapy children can actually reach — the same expertise that built the platform behind us.
Governance
Ventures operates under its own governance and investment discipline.
Investment capital and philanthropic capital never commingle.
Two paths, one mission — distinct mandates, shared purpose for children.
The Other Engine